Top Markets
#1 XPIN Network XPIN Network +20.75%
#2 Ontology Gas Ontology Gas +18.98%
#3 Neiro Neiro +18.83%
#4 Geodnet Geodnet +17.67%
#5 Derive Derive +15.55%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +13.99%
#7 Pons Pons +13.36%
#8 Status Status +13.19%
#9 Collect on Fanable Collect on Fanable +12.39%
#10 Ethena Staked ENA Ethena Staked ENA +10.96%
Coin of the day
XPIN Network XPIN Network
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

OMIC
Classement en actions #25552
Singular Genomics Systems, Inc. is a life science technology firm focused on... Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
Prix de l'action
$20.01
Dernière synchronisation: 2025-02-21
Capitalisation boursière
$48.36M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Singular Genomics Systems, Inc. (OMIC)

Catégorie

Healthcare
Bénéfices pour Singular Genomics Systems, Inc. (OMIC)
Bénéfices en Sep 2024 TTM : $-86.32M
Selon les derniers rapports financiers de Singular Genomics Systems, Inc., les bénéfices actuels de l'entreprise sont de $-86.32M. En 2022, l'entreprise a réalisé un bénéfice de $-90.88M, une augmentation par rapport à celui de 2021 qui était de $-98.77M. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Singular Genomics Systems, Inc. de 2019 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $-86.32M -8.96%
2023 $-94.82M 4.34%
2022 $-90.88M -7.99%
2021 $-98.77M 253.45%
2020 $-27.95M 126.75%
2019 $-12.32M 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
$3.81B -4,508.84%
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
$4.11B -4,859.90%
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
- -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
$1.59B -1,941.94%
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
- -
CH